Quick Answer
CVS HEALTH Corp reported Cash and Equivalents of $8.45 billion for fiscal year 2025.
CVS HEALTH Corp Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $8.45B | -1.5% |
| 2024 | $8.59B | +4.8% |
| 2023 | $8.20B | -36.7% |
| 2022 | $12.95B | +37.6% |
| 2021 | $9.41B | +19.8% |
| 2020 | $7.85B | +38.2% |
| 2019 | $5.68B | +40.0% |
| 2018 | $4.06B | +139.3% |
| 2017 | $1.70B | -49.7% |
| 2016 | $3.37B | +37.1% |
| 2015 | $2.46B | -0.9% |
| 2014 | $2.48B | -39.3% |
| 2013 | $4.09B | +197.4% |
| 2012 | $1.38B | -2.7% |
| 2011 | $1.41B | -1.0% |
| 2010 | $1.43B | +31.4% |
| 2009 | $1.09B | -19.7% |
| 2008 | $1.35B | +28.0% |
| 2007 | $1.06B | +99.2% |
| 2006 | $530.00M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $9.10B | +32.3% | -22.8% |
| June 30, 2025 | $11.79B | -5.8% | +17.0% |
| March 31, 2025 | $10.08B | +2.8% | +17.4% |
| December 31, 2024 | $8.59B | +4.8% | +24.9% |
| September 30, 2024 | $6.88B | -47.3% | -45.0% |
| June 30, 2024 | $12.51B | -9.4% | +27.6% |
| March 31, 2024 | $9.80B | -33.0% | +19.6% |
| December 31, 2023 | $8.20B | -36.7% | -37.2% |
- CVS HEALTH Corp showed a decrease of -1.5% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2006–2025 period, CVS HEALTH Corp’s cash and equivalents has grown by 1494.9% (from $530.00 million to $8.45 billion).
- The most recent figure is from CVS HEALTH Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: